Punch & Associates Investment Management Inc decreased Silvercrest Asset Mgmt Group (SAMG) stake by 9.01% reported in 2018Q3 SEC filing. Punch & Associates Investment Management Inc sold 48,834 shares as Silvercrest Asset Mgmt Group (SAMG)’s stock declined 2.74%. The Punch & Associates Investment Management Inc holds 493,000 shares with $6.83 million value, down from 541,834 last quarter. Silvercrest Asset Mgmt Group now has $185.51 million valuation. The stock increased 5.11% or $0.67 during the last trading session, reaching $13.79. About 5,699 shares traded. Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) has declined 6.19% since February 5, 2018 and is downtrending. It has underperformed by 6.19% the S&P500. Some Historical SAMG News: 06/03/2018 SILVERCREST ASSET MANAGEMENT GROUP LLC REPORTS 5.5 PCT PASSIVE STAKE IN BANCORPSOUTH BANK AS OF DEC 31, 2017 – SEC FILING; 03/05/2018 – Correct: Silvercrest Asset 1Q Adj EPS 30c, Not 31c; 15/05/2018 – Silvercrest Asset Mgmt Group Buys Into Gibraltar Industries; 09/03/2018 – Silvercrest Asset 4Q Loss/Shr 1c; 03/05/2018 – SILVERCREST ASSET MANAGEMENT GROUP – TOTAL AUM OF $21.5 BLN, INCLUSIVE OF DISCRETIONARY AUM OF $15.9 BLN & NON-DISCRETIONARY AUM OF $5.6 BLN AT MARCH 31; 03/05/2018 – Silvercrest Asset 1Q Adj EPS 31c; 03/05/2018 – Silvercrest Asset 1Q Rev $24.3M; 25/04/2018 – SAFRAN CONTINUES TALKS WITH DASSAULT ON SILVERCREST TERMINATION; 15/05/2018 – Wellington Mgmt Group Buys Into Silvercrest Asset Mgmt Class A; 03/05/2018 – Silvercrest Asset 1Q EPS 27c

Schaper Benz & Wise Investment Counsel Inc decreased Idexx Laboratories (IDXX) stake by 6.4% reported in 2018Q3 SEC filing. Schaper Benz & Wise Investment Counsel Inc sold 3,506 shares as Idexx Laboratories (IDXX)’s stock declined 20.36%. The Schaper Benz & Wise Investment Counsel Inc holds 51,309 shares with $12.81M value, down from 54,815 last quarter. Idexx Laboratories now has $17.52 billion valuation. The stock decreased 1.08% or $2.22 during the last trading session, reaching $203.16. About 532,978 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 22.67% since February 5, 2018 and is uptrending. It has outperformed by 22.67% the S&P500. Some Historical IDXX News: 04/05/2018 – IDEXX LABS 1Q REV. $538M; 04/05/2018 – IDEXX Labs 1Q EPS $1.01; 04/05/2018 – IDEXX LABS 1Q REV. $537.7M, EST. $524.8M; 04/05/2018 – IDEXX MAINTAINS 2018 REPORTED REV. GUIDANCE $2,205M – $2,245M; 04/05/2018 – IDEXX LABORATORIES INC IDXX.O FY2018 SHR VIEW $4.12, REV VIEW $2.22 BLN — THOMSON REUTERS l/B/E/S; 15/05/2018 – IDEXX LABORATORIES – REDUCED BOARD SIZE TO EIGHT & SIZE OF CLASS l TO TWO MEMBERS, EFFECTIVE UPON WILLIAM END’S RETIREMENT FROM BOARD – SEC FILING; 22/04/2018 – DJ IDEXX Laboratories Inc, Inst Holders, 1Q 2018 (IDXX); 29/03/2018 – MONTEA CVA MONTE.BR – CURRENT TENANT IDEXX EUROPE B.V. WILL CONTINUE TO RENT PREMISES AFTER TRANSFER OF OWNERSHIP UNDER CURRENT LEASE; 04/05/2018 – IDEXX Labs Backs 2018 Rev $2.205B-$2.245B; 04/05/2018 – IDEXX LABORATORIES INC IDXX.O RAISES FY 2018 SHR VIEW TO $4.06 TO $4.20

Among 3 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. IDEXX Laboratories had 3 analyst reports since August 17, 2018 according to SRatingsIntel. As per Monday, November 5, the company rating was maintained by Canaccord Genuity. As per Friday, August 17, the company rating was maintained by Credit Suisse. The rating was maintained by Bank of America with “Buy” on Friday, November 2.

Investors sentiment increased to 1.04 in 2018 Q3. Its up 0.03, from 1.01 in 2018Q2. It improved, as 25 investors sold IDXX shares while 207 reduced holdings. 82 funds opened positions while 159 raised stakes. 70.63 million shares or 1.73% less from 71.88 million shares in 2018Q2 were reported. Fiera Corp invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Cue Grp Inc Inc owns 6,485 shares or 0.97% of their US portfolio. Hillsdale Invest Mgmt reported 1,940 shares stake. 338,870 are owned by Jennison Assoc Lc. Acg Wealth holds 0.52% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 15,696 shares. Regions Fin invested 0% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Prio Wealth Ltd Partnership holds 9,080 shares or 0.1% of its portfolio. Bath Savings Tru owns 29,056 shares. Wilbanks Smith And Thomas Asset Mgmt reported 573 shares stake. 11,724 were reported by Eqis Capital Management Incorporated. Norinchukin Comml Bank The, Japan-based fund reported 11,127 shares. King Luther Mngmt Corp, a Texas-based fund reported 4,166 shares. Fifth Third Bancorp accumulated 0% or 388 shares. Shelton Capital holds 0.12% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 8,266 shares. Whittier Tru Of Nevada has 35 shares for 0% of their portfolio.

Analysts await IDEXX Laboratories, Inc. (NASDAQ:IDXX) to report earnings on February, 7. They expect $0.90 earnings per share, up 16.88% or $0.13 from last year’s $0.77 per share. IDXX’s profit will be $77.61 million for 56.43 P/E if the $0.90 EPS becomes a reality. After $1.05 actual earnings per share reported by IDEXX Laboratories, Inc. for the previous quarter, Wall Street now forecasts -14.29% negative EPS growth.

Since August 21, 2018, it had 0 insider buys, and 6 sales for $15.75 million activity. $2.84 million worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was sold by Studer Jacqueline on Tuesday, August 21. Shares for $682,992 were sold by HENDERSON REBECCA M on Tuesday, November 27. 11,372 IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares with value of $2.76 million were sold by TWIGGE GIOVANI. Shares for $7.37 million were sold by AYERS JONATHAN W on Tuesday, August 21. On Tuesday, August 21 the insider Lane Michael sold $1.44 million.

More notable recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Nasdaq.com which released: “First Week of IDXX March 15th Options Trading – Nasdaq” on January 25, 2019, also Nasdaq.com with their article: “ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions – Nasdaq” published on January 31, 2019, Nasdaq.com published: “Why Idexx Laboratories Stock Gained 19% in 2018 – Nasdaq” on January 11, 2019. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) were released by: and their article: “Jim Cramer Gives His Opinion On AbbVie, Idexx Labs And More – Yahoo! Finance News” published on January 30, 2019 as well as Seekingalpha.com‘s news article titled: “IDEXX: This Medical Equipment Stock Is Overvalued And Could Go Down As Much As 20% – Seeking Alpha” with publication date: May 18, 2018.

Since September 17, 2018, it had 1 buy, and 0 insider sales for $60,802 activity. Shares for $60,802 were bought by Dunn Brian D.

More notable recent Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) news were published by: Seekingalpha.com which released: “Silvercrest Asset Management Group: An Under-Covered Stock Worth A Second Look – Seeking Alpha” on November 19, 2018, also Seekingalpha.com with their article: “Silvercrest Asset Management Group (SAMG) CEO Rick Hough on Q2 2018 Results – Earnings Call Transcript – Seeking Alpha” published on August 05, 2018, Globenewswire.com published: “Investor Expectations to Drive Momentum within Cel-Sci, DGSE Companies, Veracyte, China Pharma, Barnwell Industries, and Silvercrest Asset Management Group — Discovering Underlying Factors of Influence – GlobeNewswire” on November 23, 2018. More interesting news about Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) were released by: Seekingalpha.com and their article: “IPO Preview: Silvercrest Asset Management Group – Seeking Alpha” published on November 14, 2012 as well as Prnewswire.com‘s news article titled: “Silvercrest Asset Management Group Inc. Reports Q3 2018 Results – PR Newswire” with publication date: November 01, 2018.

Investors sentiment increased to 2.62 in Q3 2018. Its up 0.68, from 1.94 in 2018Q2. It increased, as 1 investors sold SAMG shares while 12 reduced holdings. 6 funds opened positions while 28 raised stakes. 6.28 million shares or 2.42% more from 6.13 million shares in 2018Q2 were reported. Mendon Cap Advsrs has 0.67% invested in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) for 550,631 shares. Vanguard Gp accumulated 0% or 375,277 shares. 69,021 are owned by Ativo Cap Management Ltd. Boston Prtn holds 0.01% or 588,600 shares. Tiaa Cref Inv Ltd Liability Corporation has 0% invested in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) for 15,300 shares. Deutsche Bank Ag has invested 0% in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG). Dimensional Fund Advisors LP owns 81,617 shares or 0% of their US portfolio. Strs Ohio reported 5,400 shares. Meeder Asset Mngmt Incorporated reported 1,617 shares. Perritt Capital Mgmt reported 1.45% in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG). Great West Life Assurance Can has invested 0% in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG). Rmb Cap Management accumulated 106,275 shares. 20 were reported by Federated Investors Pa. Hilton Capital Ltd Liability has invested 0.02% in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG). Moreover, Ameritas Investment has 0% invested in Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) for 548 shares.